Ida Kim Wium-Andersen graduated as a medical doctor from University of Copenhagen in 2008. Ida is in her last year before becoming a specialist in Psychiatry. Ida started doing research during medical school examining use of alcohol and tobacco in adolescence. Later, she became interested in the link between somatic and psychiatric comorbidity and took part in a large study on cardiovascular disease, stroke and depression which was carried out in collaboration between Centre for Clinical Research and Prevention and Psychiatric Center Copenhagen. Also, she joined the research group at the Mood Disorder Psychopharmacology Unit in Toronto, Canada, working with Professor I Psychiatry Roger McIntyre on several projects in 2015. Currently, she works at a project looking at the relationship between diabetes, depression, and dementia using data from both the Danish registers and several individual cohorts, together with Professor in Epidemiology Merete Osler, Professor in Psychiatry Martin Balslev Jørgensen at Psychiatric Center Copenhagen, Professor i Endokrinologi Jørgen Rungby at Bispebjerg Hospital, and post.doc. Marie Kim Wium-Andersen.
- Wium-Andersen IK, Wium-Andersen MK, Jørgensen MB, Osler M. Anti-inflammatory treatment in stroke patients and risk of depression. Under revision in Journal of Psychiatry and Neuroscience, February 2017
- Wium-Andersen IK, Wium-Andersen MK, Jørgensen MB, Osler M. Anti-inflammatory treatment and risk of depression in patients with acute coronary syndrome. Submittet to International Journal of Cardiology, February 2017.
- Wium-Andersen, MK and Wium-Andersen, IK. C-reactive protein in bipolar disorder. Lancet Psychiatry. 2016 Dec;3(12):1096-1098
- Wium-Andersen IK, Vinberg M, Kessing LV, McIntyre RS. Personalized Medicine in Psychiatry. Nord J Psychiatry. 2017 Jan;71(1):12-19.
- Lee Y, Syeda K, Maruschak NA, Cha DS, Mansur RB, Wium-Andersen IK, Woldeyohannes HO, Rosenblat JD, McIntyre RS. A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect. J Clin Psychopharmacol. 2016 Feb;36(1):50-6